Malignant Hyperthermia
Malignant hyperthermia (MH) or malignant hyperpyrexia is a rare life-threatening condition that is triggered by exposure to certain drugs used for general anaesthesia — specifically the volatile anaesthetic agents and suxamethonium, a neuromuscular blocking agent.
General Information
For Patients
If you have been told you or one of your family suffers from Malignant Hyperthermia see our information here.
For Geneticists
Many MH families appear to have more than one genetic factor contributing to the risk of MH susceptibility.
For Anaesthetists
MH is an acute pharmacogenetic disorder, which develops during or immediately after the application of general anaesthesia.
Learn More
Operating Room Staff & anaesthetists
Malignant Hyperthermia
Resource Kit
If you work as an Operating Suite Staff or as an Anaesthetists, MHANZ have developed a Resource Kit for MH.
MH Poster
MH Initial Management
MH Crisis Coordinator
